(S)-beta-(p-Fluorophenyl)alanine, 97.0%, 5g

C-[1-(4-Fluoro-benzenesulfonyl)-piperidin-3-yl]-methylamine hydrochloride, 95.0%, 250mg

Ethyl 2-methylisonicotinate, 97%, 100mg

4-Bromo-2-methoxy-3-methylpyridine, 95.0%, 250mg

2-Chloro-3,4-difluorobenzaldehyde, 95.0%, 5g

Trial kit Spectra/Por® Biotech CE, 8000–10000 dalton(s), 1 Piece(s)

2-Fluoro-4-nitrobenzaldehyde, 95.0%, 25g

3-Phenyl-p-anisidine hydrochloride, 95.0%, 5g

2-(3,4-Difluoro-5-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 1g

9-(4,6-dichloro-1,3,5-triazin-2-yl)-9H-carbazole, 98+%, 5g

(5-Bromoquinolin-8-yl)methanamine, 98%, 250mg

4-Iodobenzene-1,2-diol, 98%, 1g

(4-Chloropyridine-2-yl)methanol, 95.0%, 5g